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Abstract Acute lymphocytic leukemia (ALL) is an
outrageous disease worldwide. L-Asparagine (L-Asn) and L-
glutamine (L-Gln) deamination plays crucial role in ALL
treatment. Role of Erwinaze (L-asparaginase from Er-
winia chrysanthemi) in regulation of L-Asn and L-Gln has
been confirmed by the experimental studies. Therapeutic
research against ALL remained elusive with the lack of
structural information on Erwinaze enzyme. In this pre-
sent study, homology model of the Erwinaze was devel-
oped using MODELLER and the same was validated by
various quality indexing tools. For the apo state enzyme
and ligand bound state complexes molecular dynamics
(MD) simulation was performed. The trajectory analysis
showed the confirmational changes of structures in the
dynamic system. Ligand binding mechanisms were studied
using different docking tools to interpret the various
ligand-receptor interactions and binding free energies. MD
simulation of docked complex with L-Gln ligand substrate
showed the defined structural folding with stable confor-
mation over the L-Asn complex in dynamic environment.
This research reports give much more information on
structural and functional aspects of Erwinaze with its
ligands which may be useful in designing of effective
therapeutics for ALL.
Keywords L-Asparaginase  Erwinaze  Molecular
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Introduction
Leukemic cell’s inability to synthesize L-Asn on their own
has primed L-Asparaginase enzyme as a dynamic factor of
chemotherapy in acute lymphoblastic leukemia (ALL)
therapy (Ohnuma et al. 1970; Wriston and Yellin 1973). In
blood vascular system, L-Asparaginase hydrolyses L-Asn
into L-Aspartic acid and ammonia building the leukemic
cells barren of essential exogenous L-Asn, leading to pro-
tein synthesis inhibition followed by apoptosis (Lubkowski
et al. 1994; Neuman and McCoy 1956; Mashburn and
Wriston 1964), hence making this potent against ALL.
Nowadays, salable L-Asparaginases are predominantly
produced from E. coli and Erwinia chrysanthemi (Godfrin
and Bertrand 2006). Apart from direct production from
various bacterial and fungal strains, several attempts were
also made for the production of recombinant enzyme by
cloning and expression of L-Asparaginase encoding genes
from Erwinia chrysanthemi (Kotzia and Labrou 2007) and
Erwinia carotovora (Kotzia and Labrou 2005) and other
microbes in E. coli. It is found that against the cells of
reverted ALL patients, the commercial anti-cancer enzyme
has in vitro resistance (Klumper et al. 1995) along with its
high glutaminase activity and low substrate specificity,
causing pancreatitis, liver dysfunction, coagulation
anomalies causing intracranial thrombosis or hemorrhage,
neurological seizures and leucopenia (Duval et al. 2002). L-
Glutaminase activity of same enzyme leading to deami-
nation of L-Gln to L-Glutamate in blood plasma induces
some toxic effects in normal cells (Capizzi and Cheng
1981; Storti and Quaglino 1970). This facilitates the
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necessity for novel and healthy L-Asparaginases from
innocuous microorganisms with elevated substrate affinity,
amended stability, low glutaminase activity, adequate half-
life and least KM value under physiological conditions to
overcome the above said challenges encountered in the
recent scenario. Though we have sufficient data on the
production, optimization of bioprocess and purification of
enzyme etc., no research has been done on the molecular
aspects of the enzyme from Erwinia chrysanthemi. In the
absence of crystal structure it is highly difficult to get the
molecular information about the enzyme like its interac-
tions with the substrates, enzyme stability etc. Therefore,
the current study is aimed towards the in silico modeling of
L-Asparaginase structure from Erwinia chrysanthemi,
molecular interactions with the substrates through docking,
and testing the stability of the enzyme and docked com-
plexes under physiological conditions by molecular
dynamic simulations methods.
Materials and methods
Preparation of receptor and ligands
Ligand molecules L-Asn (C4H8N2O3) and L-Gln
(C5H10N2O3) whose molecular masses are 132.12 g/mol
and 146.14 g/mol were retrieved from Zinc database with
ID numbers 1532556 and 1532526, respectively. Then they
were subjected to energy minimization using the MMFF
(Merck Molecular Force Field) (Halgren 1996) of VLi-
feMDS v 4.3 that works based on MM3 force fields until
reaching global minima.
Homology modeling approach was used to investigate
the tertiary structure of the enzyme. Hypothetical config-
uration of enzyme was obtained by MODELLER v 9.13
tool using amino acid sequence provided by Drugbank
(http://www.drugbank.ca/drugs/DB08886). Further the
modeled enzyme was validated using Ramachandran plot
analysis by Rampage (Lovell et al. 2003), followed by
determination of QMEAN 6 score (Benkert et al. 2008),
DFire energy value (Zhou and Zhou 2002) using SWISS-
MODEL server and ERRAT 2.0 (Colovos and Yeates
1993) tools to verify the stereochemical quality of the
model by analyzing the phi (ø) and psi (w) torsion angles,
estimation of local quality of the modeled enzyme,
assessment of non-bonded atomic interactions and for
appraising the growth of crystallographic model construc-
tion and refinement, respectively.
Molecular docking
iGEMDOCK v 2.1 is a graphical atmosphere for identify-
ing the pharmacological interactions and virtual screening
that are beneficial for pinpointing the lead compounds and
understanding the mechanism of ligand binding against a
therapeutic target. iGEMDOCK, a flexible docking tool
can be used for the docking, virtual screening and post-
screening analysis. The post analysis tools works by using
K means and hierarchal clustering methods (Hsu et al.
2011).
Interactive interface was provided initially for preparing
target protein’s binding site and compound library
screening in GEMDOCK. The complete modeled structure
of Erwinaze was uploaded in the ‘‘Prepare Binding Site’’
and the ‘‘By current file’’ choice was kept because the
uncut surface will be checked for binding, instead of
specifying a single cavity. Then the in-house docking tool
GEMDOCK docks the compounds from library into
receptor binding site. Protein-compound interaction pro-
files were generated and analyzed by post analysis tools.
iGEMDOCK finally ranks and visualizes the compound
based on energy based scoring function and pharmaco-
logical interactions (Kaladhar 2012). During docking pro-
cess, GA parameters were set as population size of 300,
generations of 80 and solutions number as 10.
Stable docking (slow) was performed with the docking
scoring function as GEMDOCK scoring function and 1.00
was set to ligand hydrophobic and electrostatic preferences.
Low energy profile indicates the stable system and it rep-
resents the likely binding interaction.
To verify the results obtained by iGEMDOCK, again
molecular docking was performed by Patch Dock server by
uploading the structures to web server (Schneidman-
Duhovny et al. 2005) that works based on shape comple-
mentarity principles and again the outcomes were refined
with FireDock server (Andrusier et al. 2007; Mashiach
et al. 2008) that reshuffles the interface side chains and
amends the molecule’s relative orientation. Analysis of
ligand binding interactions and docking viability was
established on Fire Dock scores and visualizations with
Pymol. Docking parameters were set as 30˚ as rotation
angle, 30 as number of placements and 10 as ligand wise
results. Intel Core i7 7470 CPU @ 3.40 GHz of DELL
origin, with 8 GB DRR RAM under Windows 8.1 OS was
used to perform all the docking runs.
Molecular dynamics and simulation
MD simulations were executed for the homology modeled
Erwinaze enzyme, Erwinaze-L-Asn (complex 1) and
Erwinaze-L-Gln (complex 2) docked complexes devel-
oped from molecular docking to ratify the stability for anti-
cancer enzyme in apo state and bound state with the sub-
strates in dynamic system. Generating the L-Asn and L-Gln
topologies using PRODRG server was the early step in MD
simulations (SchuE`ttelkopf and Van Aalten 2004). After
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defining ligand topologies, MD simulation for modeled
enzyme and docked complex were carried using GRO-
MACS 4.6.5 program package under Ubuntu 14.04 oper-
ating system. Steepest algorithm using the GROMOS 96
43a1 (van Gunsteren et al. 1996; Scott et al. 1999) was
used for energy minimization, dismissing when the maxi-
mum force was found lesser than 1000 kJ mol-1 nm-1.
The modeled enzyme and the docked complexes were
solvated in the system of a cubic box with a size of 1.0 nm
and at least 2.0 nm between any two periodic images of a
protein to provide an aqueous environment. With the
addition of one chlorine ion the system was neutralized and
periodic boundary conditions were applied in all directions.
The cubic interpolation order in particle mesh Ewald
(PME) simulation method was 4 and the grid spacing for
FFT (Fourier spacing) was 0.16. In the neighbor searching
method, the short range neighbor list cutoff of 1 A˚ was
taken commonly for electrostatic interactions and Vander
Walls interactions. The LINCS (Hess et al. 1997) and
SETTLE algorithms (Miyamoto and Kollman 1992) were
applied to constrain all bond lengths and geometry of water
molecules, respectively. For 100 ps duration, the two
equilibration phases NVT ensemble with a constant tem-
perature of 300 K, coupling constant of 0.1 ps and NPT
ensemble with constant pressure of 1 bar, coupling con-
stant of 2 ps were applied for all the molecules. Modified
Berendsen thermostat coupling scheme algorithm was
employed for both ensembles of equilibration. Once the
system equilibration with constant temperature and pres-
sure was done, to carry out the structural and energy
analyses30 ns production MD run was performed. Run
trajectories were obtained and with GROMACS utilities
analysis was carried out. Using g_energy, g_rms, g_rmsf
and g_gyrate quality assurance of all the molecules was
performed. g_hbond was used to cross check the docking
results in terms of hydrogen bonding pattern between the
receptor and ligand substrates. Using Xmgrace tool the
entire trajectory results were analyzed (Turner 2005).
Results and discussion
Molecular modeling of L-asparaginase from Erwinia
chrysanthemi
For predicting protein three-dimensional structure based on
user provided alignment of a sequence to be modeled with
known related structures, homology or comparative mod-
eling tool MODELLER can be used. BLAST search was
performed to identify the most similar sequences whose
crystal structures were experimentally determined. Search
results suggested 1HFJ_A, 1O7J_A, 1ZCF_A and 2JK0_A
as potential templates of bacterial origin having 99, 98, 79
and 79 % of sequence identity and SuperPose (http://
wishart.biology.ualberta.ca/superpose/) gave the backbone
RMSD values of 0.31, 0.37, 0.83 and 0.43 nm, respec-
tively, from the query. Calculation of a model containing
all non-hydrogen atoms was automatically done by
MODELLER using all the four templates to cover the
complete query sequence. Best homology model was
chosen based on the low discrete optimized protein energy
(DOPE) score and RMSD values amongst a total of ten
models predicted by MODELLER (Sˇali and Blundell 1993;
Fiser et al. 2000).
The hypothetical model of Erwinaze enzyme (Fig. 1)
was validated using Rampage geometric evaluations to get
Ramachandran plot. The plot has 97.2, 2.8 and 0.0 %of
residues in favored, allowed and disallowed regions,
respectively, and this strongly supports the geometric fit-
ness of the modeled enzyme. Qmean6 score of 0.671,
DFire energy of -455.15 and 84.326 % overall quality
factors from ERRAT 2.0 indicates the good resolution
structure. Secondary structure of the protein was also
analyzed using PredictProtein tool (http://www.
predictprotein.org). Protein was rich in loop region with a
percentage of 46.01 residues and the remaining 29.14 and
24.85 % ones as helix and strands with two N-glycosyla-
tion sites in it. Along with these it also has eight sites for
protein kinase C phosphorylation, three sites for Casein
kinase II phosphorylation and one Tyrosine kinase phos-
phorylation. The final structure was further used to study
the molecular interactions with ligand molecule.
Docking with L-Asn and L-Gln
Two ligand substrates namely L-Asn and L-Gln were
docked into the catalytic site of Erwinaze. Dock runs of
ligands on the enzyme were done using iGEMDOCK v 2.1
and PatchDock server. When docking runs were carried out
by iGEMDOCK, Erwinaze has shown very high binding
affinity with L-Asn and L-Gln (-52.6373 kcal/mol and
-57.2457 kcal/mol, respectively). Results obtained by
iGEMDOCK were again validated by PatchDock
Fig. 1 Structure of Erwinaze predicted by MODELLER
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webserver followed by refinement of obtained results with
FireDock server.
Outcomes strongly supported the previous results with a
very good binding efficiency between receptor and ligands
with the calculated global energy values of -20.41 kcal/-
mol and -25.32 kcal/mol for L-Asn and L-Gln, respec-
tively, by FireDock server. L-Asn made inter molecular
hydrogen bonds with THR-15, THR-26, THR-27 and
MET-121 of Erwinaze and on the other side L-Gln gen-
erated bonds with THR-165, THR-167 and ASN-180 of
same enzyme (Table 1). In fact, the enzyme has more
affinity towards L-Asn; as it has formed the four inter
molecular hydrogen bonds with the ligand atoms with the
distances of 2.6, 2.5, 3.4 and 2.7 A˚ which are lesser com-
pared to the bond lengths resulted with L-Gln.
Summary of the binding energies by all the docking
methods were described in Table 2. The mode of binding
and cavity of ligands with receptor was visualized in
PyMol molecular graphics viewer (Fig. 2). Cross checking
of the modeled enzyme binding sites in docking was done
with active site prediction tool (Ngan et al. 2012; Brenke
et al. 2009). Pooled results exhibited matching of most of
the residues, and thus, the binding sites used in docking
approach were well defined (Supplementary material). As
the exertion of biological activity of any drug is based on
the binding between protein and ligand, present investi-
gation results reveal that the nearly equal affinity of
Erwinaze towards both the ligands strongly supports
Asparaginase and Glutaminase activities of the enzyme
(Keating et al. 1993; Derst et al. 2000). Numerous adverse
effects of L-Asparaginase usage have also been stated,
distant from severe immunogenic reactions (Kwon et al.
2009).
MD simulations: protein in water
To check the structural behavior of modeled enzyme and
docked complexes in the dynamic system MD simulations
were performed and the trajectory analysis was done using
GROMACS utilities. The total energy found from g_en-
ergy results for Erwinaze modeled enzyme was found to
Table 1 Molecular Interactions between Erwinaze and ligand
substrates
S.No. Ligand Residue and atom Ligand atom Bond length (A˚)
1 L-Asn THR15 & OG1 O3 2.6
2 THR26 & O N1 2.5
3 THR27 & OG1 N1 3.4
4 MET121 & O N2 2.7
5 L-Gln TYR165 & O N2 2.6
6 THR167 & OG1 N2 3.5
7 THR167 & N O2 2.9
8 ASN180 & N O3 3.3
Table 2 Molecular Docking results of Erwinaze with ligand
substrates
Docking tool Ligand
L-Asn (kcal/mol) L-Gln (kcal/mol)
iGEMDOCK -52.6373 -57.2457
PatchDock and FireDock -20.41 -25.321
Fig. 2 Molecular docking
results of Erwinaze with
ligand substrates a binding with
L-Asn, b binding with L-Gln
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be -9,30,919 kJ/mol demonstrating that the model was
energetically stable (Fig. 3). The structural convergence
includes terms like root mean square deviation (RMSD),
root mean square fluctuation (RMSF), radius of gyration
(Rg) and hydrogen bond (H-bond) analysis. In the g_rms
based results with backbone atoms (Fig. 4), apo state
enzyme is stable right from the launch of MD run with a
drift at 10 ns followed by a stable confirmation till the
finale of entire run.
In case of docked complexes, though the complex 1 is
unwavering till 20 ns it exhibited an increasing path later
and extended the RMSD value to virtually 0.4 nm. RMSD
of complex 1 with L-Asn till 10 ns specified the ligand
binding in apo state and after 10 a significant conforma-
tional change with deviation was observed which might be
the plausible cause to obtain L-Asn bound state. Its high
RMSD value shows the instability of the complex which is
undesirous. On the other hand, complex 2 has shown a
perpetual RMSD value around 0.3 nm showing its high
stability in the 300K atmosphere supporting the
Fig. 3 Total energy of Erwinaze apo enzyme after molecular
dynamics and simulations
Fig. 4 RMSD of backbone atoms for apo state enzyme,
Erwinaze ? L-Asn and Erwinaze ? L-Gln complexes
Fig. 5 RMSF of Ca atoms for apo state enzyme, Erwinaze ? L-Asn
and Erwinaze ? L-Gln complexes
Table 3 Comparison of RMSF values from MD simulations
S. no. Residue RMSF (nm)
Erwinaze
in apo state
Complex 1 Complex 2
1 TYR15 0.0905 0.1108 0.0832
2 THR 26 0.5626 0.4778 0.3424
3 THR27 0.4196 0.4855 0.3730
4 MET121 0.1318 0.1355 0.0938
5 TYR165 0.0647 0.0736 0.0677
6 THR167 0.0616 0.0839 0.0722
7 ASN180 0.1866 0.2255 0.1255
Fig. 6 Rg plots for apo state enzyme, Erwinaze ? L-Asn and
Erwinaze ? L-Gln complexes
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experimental results of neurotoxicity (Capizzi and Cheng
1981; Storti and Quaglino 1970) of L-Glutaminase nature
of enzyme. This leaves the plasma pool L-Asn free for the
uptake by cancerous cells on one hand because of unsta-
ble nature of complex 1, and causing the toxicity in normal
cells due to its stable Glutaminase activity. Both the
complexes are displaying their undesirable results against
the actual desired L-Asparaginase role of enzyme in cancer
therapy.
In the analysis of g_rmsf results, many oscillations in
the residues with Ca atoms were observed in case of first
complex with a fall and amendment in initial peak due to
the binding of L-Asn in that region. This substrate binding
also influenced the entire enzyme with several numbers of
residual fluctuations with a near RMSF value of 0.3 nm
(Fig. 5). The same plot also disclosed the presence of a
second high peak in the vicinity of bounded residues
establishing H-bonds with ligand leading to a very high
RMSF value of around 0.6 nm in complex 2, leaving most
of the other residues stable. The comparison of RMSF
outcomes exhibited minor variations in ligand binding sites
(Table 3) and their effect on complex formation.
Radius of gyration (Rg) was done to analyze the struc-
tural compactness of enzyme and was calculated using
g_gyrate tool of GROMACS. Though the modeled enzyme
in its free state has some structural compactness, bounded
complexes were shown their fluctuating nature from Rg
plots. Complex 1 has displayed the drifts during entire MD
run in the array of 2.0 and 2.08 nm. In the plot of complex
2, it revealed its compactness with a little drift at 15 ns
time point with the Rg values oscillating between 2.0 and
2.06 nm (Fig. 6).
To authenticate the hydrogen bonding pattern docking
results, H-bond analysis was also executed along with the
intact MD trajectories (Fig. 7). Surprisingly, the desired
stable H-bonding pattern for complex 1 described missing
linkage of hydrogen bonds between receptor and ligand.
During 7.5 ns point the H-bonds were increased to 5, but
after 4.03 ns h-bonds were missed and again formed from
6 ns. The same was again repeated at around 9 ns and
11 ns time points. Finally, after 12.6 ns there were no
h-bonds, showing the disappearance of H-bond linkage
between enzyme and substrate (Fig. 7a). The loss of
intermolecular hydrogen bands may induce a spatial con-
formational change in the tertiary structure of the enzyme
i.e., unstable structure of docked complex. This becomes a
major shortcoming for the enzyme in therapeutic perspec-
tive, supporting possibility of its lower effect on cancer
cells. On the other hand, it has shown the constant H-bond
pattern with L-Gln throughout MD run with an average of 7
H-bonds throughout entire trajectory (Fig. 7b). H-bond
pattern of both complexes did not draw a parallel with the
docking result and this gives scope for the further inves-
tigation for efficient and firm drug in ALL therapy. Entire
computational analysis describes the necessity of further
intensive investigation on other sources of L-Asparaginase
enzyme which is more effective on cancerous cells with
fewer side effects.
Conclusion
L-Asparaginase is one of the most attractive enzymes in
cancer research. Investigational studies on Erwinaze
sustained it as one of the therapeutic agent for ALL. In the
present computational study, hypothetical model of
Erwinaze enzyme was developed and MD simulations for
the same in apo state confirmed its stability. Ligand bind-
ing studies on Erwinaze with L-Asn and L-Gln using
molecular docking explained the binding mechanism of
Fig. 7 Inter-hydrogen bonding
for docked complexes
a Erwinaze ? L-Asn,
b Erwinaze ? L-Gln
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docked complexes. Key residues in binding were identified
as Thr 15, Thr 26, Thr 27and Met 121 in L-Asn binding
followed by Tyr 165, Thr 167 and Asn 180 in L-Gln
binding based on the docking results. MD simulations of
complex 1 for 30 ns run confirmed the instability and
unlikeliness of enzyme towards L-Asn and the kinship with
L-Gln in the dynamic system with stability. Quite a few
conformational changes in enzyme were observed with
Erwinaze structure due to the L-Asn ligand binding
compared to L-Gln binding. This in silico studies favor
added extensive structural research on L-Asparaginase
towards scheming of potential inhibitors that aim the L-
Asparaginase for effective treatment of ALL.
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